Processing of proaugurin is required to suppress proliferation of tumor cell lines

Molecular Endocrinology

Volumn 25, Issue 5, 2011, Pages 776-784

  Ozawa, Akihiko ^a   Lick, Adam N ^a   Lindberg, Iris ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; FORSKOLIN; FURIN; METALLOPROTEINASE; PROAUGURIN; SECRETORY PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN SECRETION; SECRETORY GRANULE; SULFATION; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FURIN; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NEOPLASM PROTEINS; PROPROTEIN CONVERTASES; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SECRETORY PATHWAY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 79955772931     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0389     Document Type: Article

References (51)

1. Mirabeau O, Perlas E, Severini C, Audero E, Gascuel O, Possenti R, Birney E, Rosenthal N, Gross C 2007 Identification of novel peptide hormones in the human proteome by hidden Markov model screening. Genome Res 17:320-327
2. Götze S, Feldhaus V, Traska T, Wolter M, Reifenberger G, Tannapfel A, Kuhnen C, Martin D, Müller O, Sievers S 2009 ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer 9:447
3. Li LW, Yu XY, Yang Y, Zhang CP, Guo LP, Lu SH 2009 Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo. Int J Cancer 125:1505-1513
4. Li W, Liu X, Zhang B, Qi D, Zhang L, Jin Y, Yang H 2010 Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion. J Exp Clin Cancer Res 29:89
5. Kujuro Y, Suzuki N, Kondo T 2010 Esophageal cancer-related gene 4 is a secreted inducer of cell senescence expressed by aged CNS precursor cells. Proc Natl Acad Sci USA 107:8259-8264
6. Tadross JA, Patterson M, Suzuki K, Beale KE, Boughton CK, Smith KL, Moore S, Ghatei MA, Bloom SR 2010 Augurin stimulates the hypothalamo-pituitary-adrenal axis via the release of corticotrophin-releasing factor in rats. Br J Pharmacol 159:1663-1671
7. Huh YH, Ryu JH, Shin S, Lee DU, Yang S, Oh KS, Chun CH, Choi JK, Song WK, Chun JS 2009 Esophageal cancer related gene 4 (ECRG4) is a marker of articular chondrocyte differentiation and cartilage destruction. Gene 448:7-15
8. Moore KL 2003 The biology and enzymology of protein tyrosine O-sulfation. J Biol Chem 278:24243-24246
9. Moore KL 2009 Protein tyrosine sulfation: a critical posttranslation modification in plants and animals. Proc Natl Acad Sci USA 106: 14741-14742
10. Murthy AS, Mains RE, Eipper BA 1986 Purification and characterization of peptidylglycine alpha;-amidating monooxygenase from bovine neurointermediate pituitary. J Biol Chem 261:1815-1822
11. Barnea A, Cho G 1983 Acetylation of adrenocorticotropin and β-endorphin by hypothalamic and pituitary acetyltransferases. Neuroendocrinology 37:434-439
12. Steiner DF 1998 The proprotein convertases. Curr Opin Chem Biol 2:31-39
13. Nillni EA, Friedman TC, Todd RB, Birch NP, Loh YP, Jackson IM 1995 Pro-thyrotropin-releasing hormone processing by recombinant PC1. J Neurochem 65:2462-2472
14. Friedman TC, Loh YP, Cawley NX, Birch NP, Huang SS, Jackson IM, Nillni EA 1995 Processing of prothyrotropin-releasing hormone (Pro-TRH) by bovine intermediate lobe secretory vesicle membrane PC1 and PC2 enzymes. Endocrinology 136:4462-4472
15. Sanchez VC, Goldstein J, Stuart RC, Hovanesian V, Huo L, Munzberg H, Friedman TC, Bjorbaek C, Nillni EA 2004 Regulation of hypothalamic prohormone convertases 1 and 2 and effects on processing of prothyrotropin-releasing hormone. J Clin Invest 114: 357-369
16. Peinado JR, Li H, Johanning K, Lindberg I 2003 Cleavage of recombinant proenkephalin and blockade mutants by prohormone convertases 1 and 2: an in vitro specificity study. J Neurochem 87:868-878
17. Nakayama K 1997 Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 327:625-635
18. Kessenbrock K, Plaks V, Werb Z 2010 Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52-67
19. Thomas G 2002 Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 3:753-766
20. Rockwell NC, Krysan DJ, Komiyama T, Fuller RS 2002 Precursor processing by kex2/furin proteases. Chem Rev 102:4525-4548
21. Molloy SS, Anderson ED, Jean F, Thomas G 1999 Bi-cycling the furin pathway: from TGN localization to pathogen activation and embryogenesis. Trends Cell Biol 9:28-35
22. Southey BR, Amare A, Zimmerman TA, Rodriguez-Zas SL, Sweedler JV 2006 NeuroPred: a tool to predict cleavage sites in neuropeptide precursors and provide the masses of the resulting peptides. Nucleic Acids Res 34:W267-W272
23. Zhou A, Mains RE 1994 Endoproteolytic processing of proopiomelanocortin and prohormone convertases 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 or 2. J Biol Chem 269:17440-17447
24. Paquet L, Zhou A, Chang EY, Mains RE 1996 Peptide biosynthetic processing: distinguishing prohormone convertases PC1 and PC2. Mol Cell Endocrinol 120:161-168
25. Paquet L, Bergeron F, Boudreault A, Seidah NG, Chrétien M, Mbikay M, Lazure C 1994 The neuroendocrine precursor 7B2 is a sulfated protein proteolytically processed by a ubiquitous furin-like convertase. J Biol Chem 269:19279-19285
26. Galanopoulou AS, Kent G, Rabbani SN, Seidah NG, Patel YC 1993 Heterologous processing of prosomatostatin in constitutive and regulated secretory pathways. Putative role of the endoproteases furin, PC1, and PC2. J Biol Chem 268:6041-6049
27. Kacprzak MM, Peinado JR, Than ME, Appel J, Henrich S, Lipkind G, Houghten RA, Bode W, Lindberg I 2004 Inhibition of furin by polyarginine-containing peptides: nanomolar inhibition by nona-D-arginine. J Biol Chem 279:36788-36794
28. Seidah NG, Chrétien M, Day R 1994 The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions. Biochimie 76:197-209
29. Klimpel KR, Molloy SS, Thomas G, Leppla SH 1992 Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc Natl Acad Sci USA 89:10277-10281
30. Singh Y, Chaudhary VK, Leppla SH 1989 A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo. J Biol Chem 264:19103-19107
31. Su T, Liu H, Lu S 1998 [Cloning and identification of cDNA fragments related to human esophageal cancer]. Zhonghua Zhong Liu Za Zhi 20:254-257
32. Vanaja DK, Ehrich M, Van den Boom D, Cheville JC, Karnes RJ, Tindall DJ, Cantor CR, Young CY 2009 Hypermethylation of genes for diagnosis and risk stratification of prostate cancer. Cancer Invest 27:549-560
33. Mori Y, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Kurehara H, Mori R, Tomoda K, Ogawa R, Katada T, Harata K, Fujii Y 2007 Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Oncol Rep 18:981-985
34. Yue CM, Deng DJ, Bi MX, Guo LP, Lu SH 2003 Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma. World J Gastroenterol 9:1174-1178
35. Huang SC, Yu DH, Wank SA, Mantey S, Gardner JD, Jensen RT 1989 Importance of sulfation of gastrin or cholecystokinin (CCK) on affinity for gastrin and CCK receptors. Peptides 10:785-789
36. Gigoux V, Escrieut C, Silvente-Poirot S, Maigret B, Gouilleux L, Fehrentz JA, Gully D, Moroder L, Vaysse N, Fourmy D 1998 Met- 195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state. J Biol Chem 273:14380-14386
37. Gigoux V, Maigret B, Escrieut C, Silvente-Poirot S, Bouisson M, Fehrentz JA, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy AD 1999 Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin. Protein Sci 8:2347-2354
38. Vishnuvardhan D, Beinfeld MC 2000 Role of tyrosine sulfation and serine phosphorylation in the processing of procholecystokinin to amidated cholecystokinin and its secretion in transfected AtT-20 cells. Biochemistry 39:13825-13830
39. Ouyang YB, Moore KL 1998 Molecular cloning and expression of human and mouse tyrosylprotein sulfotransferase-2 and a tyrosylprotein sulfotransferase homologue in Caenorhabditis elegans. J Biol Chem 273:24770-24774
40. Ouyang Y, Lane WS, Moore KL 1998 Tyrosylprotein sulfotransferase: purification and molecular cloning of an enzyme that catalyzes tyrosine O-sulfation, a common posttranslational modification of eukaryotic proteins. Proc Natl Acad Sci USA 95:2896-2901
41. Beisswanger R, Corbeil D, Vannier C, Thiele C, Dohrmann U, Kellner R, Ashman K, Niehrs C, Huttner WB 1998 Existence of distinct tyrosylprotein sulfotransferase genes: molecular characterization of tyrosylprotein sulfotransferase-2. Proc Natl Acad Sci USA 95:11134-11139
42. Michnick DA, Pittman DD, Wise RJ, Kaufman RJ 1994 Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage. J Biol Chem 269:20095-20102
43. Pittman DD, Tomkinson KN, Michnick D, Selighsohn U, Kaufman RJ 1994 Posttranslational sulfation of factor V is required for efficient thrombin cleavage and activation and for full procoagulant activity. Biochemistry 33:6952-6959
44. Bergeron E, Basak A, Decroly E, Seidah NG 2003 Processing of α4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage. Biochem J 373:475-484
45. Kang T, Nagase H, Pei D 2002 Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network. Cancer Res 62:675-681
46. Viale A, Ortola C, Hervieu G, Furuta M, Barbero P, Steiner DF, Seidah NG, Nahon JL 1999 Cellular localization and role of prohormone convertases in the processing of pro-melanin concentrating hormone in mammals. J Biol Chem 274:6536-6545
47. Siegfried G, Basak A, Cromlish JA, Benjannet S, Marcinkiewicz J, Chrétien M, Seidah NG, Khatib AM 2003 The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J Clin Invest 111:1723-1732
48. McColl BK, Paavonen K, Karnezis T, Harris NC, Davydova N, Rothacker J, Nice EC, Harder KW, Roufail S, Hibbs ML, Rogers PA, Alitalo K, Stacker SA, Achen MG 2007 Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2. FASEB J 21:1088-1098
49. Lamango NS, Zhu X, Lindberg I 1996 Purification and enzymatic characterization of recombinant prohormone convertase 2: stabilization of activity by 21 kDa 7B2. Arch Biochem Biophys 330:238-250
50. Zhou Y, Lindberg I 1993 Purification and characterization of the prohormone convertase PC1(PC3). J Biol Chem 268:5615-5623
51. Sarac MS, Cameron A, Lindberg I 2002 The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in vivo. Infect Immun 70:7136-7139